# Dolores Isla

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/dolores-isla/

## Facts

| Field | Value |
| --- | --- |
| Citations | 20,072 |
| Field | Lung Cancer Treatments and Mutations |
| h-index | 44 |
| i10-index | 134 |
| Last Known Institution | Hospital Clínico Universitario Lozano Blesa |
| OpenAlex ID | https://openalex.org/A5080358046 |
| ORCID iD | https://orcid.org/0000-0002-2483-198X |
| Works | 362 |

## Researcher papers

- [Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial](https://scholariq.org/papers/erlotinib-versus-standard-chemotherapy-as-first-line-treatment-for-european/)
- [Trastuzumab Emtansine (T-DM1) in Patients with Previously Treated HER2-Overexpressing Metastatic Non–Small Cell Lung Cancer: Efficacy, Safety, and Biomarkers](https://scholariq.org/papers/trastuzumab-emtansine-t-dm1-in-patients-with-previously-treated-her2/)

## Researcher topics

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Lung Cancer Research Studies](https://scholariq.org/topics/lung-cancer-research-studies/)
- [Lung Cancer Diagnosis and Treatment](https://scholariq.org/topics/lung-cancer-diagnosis-and-treatment/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Cancer Genomics and Diagnostics](https://scholariq.org/topics/cancer-genomics-and-diagnostics/)

## Researcher university

- [Hospital Clínico Universitario Lozano Blesa](https://scholariq.org/institutions/hospital-clinico-universitario-lozano-blesa/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.